Sterling Biotech reports standalone net loss of Rs 109.51 crore in the September 2016 quarter

Sales decline 18.82% to Rs 86.89 crore

Net Loss of Sterling Biotech reported to Rs 109.51 crore in the quarter ended September 2016 as against net loss of Rs 94.21 crore during the previous quarter ended September 2015. Sales declined 18.82% to Rs 86.89 crore in the quarter ended September 2016 as against Rs 107.03 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales86.89107.03 -19 OPM %-7.4013.89 -PBDT-101.74-69.25 -47 PBT-167.47-139.46 -20 NP-109.51-94.21 -16

Powered by Capital Market - Live News